APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Isotopes

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Selected research

Market Outlook & Growth Opportunities

Global Medical Isotopes Market Outlook and Growth Opportunities 2026

31 December 2025206 pages

Choose your research edition.

Industry ResearchMedical Isotopes Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Isotopes Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Medical Isotopes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Isotopes Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Isotopes Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

A medical isotope is an isotope used in medicine. The first uses of isotopes in medicine were in radiopharmaceuticals, and this is still the most common use. However more recently, separated stable isotopes have also come into use.

In general, most isotope suppliers are not direct manufacturers because the direct manufacturers come from nuclear power plants. Isotope suppliers are generally authorized by the National Nuclear Energy Agency or signed an exclusive agreement. In addition, in the market, subsidiaries of the National Nuclear Energy Corporation are also the largest suppliers.

Many medical products today are sterilised by gamma rays from a Co-60 source, a technique which generally is much cheaper and more effective than steam heat sterilisation. The disposable syringe is an example of a product sterilised by gamma rays. Because it is a 'cold' process radiation can be used to sterilise a range of heat-sensitive items such as powders, ointments, and solutions, as well as biological preparations such as bone, nerve, and skin to be used in tissue grafts. Large-scale irradiation facilities for gamma sterilisation are installed in many countries. Smaller gamma irradiators, often utilising Cs-137, having a longer half-life, are used for treating blood for transfusions and for other medical applications. Sterilisation by radiation has several benefits. It is safer and cheaper because it can be done after the item is packaged. The sterile shelf-life of the item is then practically indefinite provided the seal is not broken. Apart from syringes, medical products sterilised by radiation include cotton wool, burn dressings, surgical gloves, heart valves, bandages, plastic, and rubber sheets and surgical instruments. Within the United States and other parts of the developed world, the trend has been to reduce the use of Co-60. And many U.S. hospitals have shifted to generating highly energetic beams with accelerator technology for such therapy. But much of the developing world still employs Co-60 mainly because of the capital costs associated with switching to alternative non-radioactive source technologies.

Read the full market overview

North America is the largest consumer by regions. Europe is the second largest with 26% market share. Asia Pacific s the following consumption region with 15% consumption market share. While the U.S. produces a significant number of the isotopes used by researchers, industry and the medical community, the U.S. is dependent upon foreign sources for many. Historically the U.S. provided almost all of the isotopes that were required for domestic consumption or, in special cases, acquired them from long-time allies. But beginning in the 1990’s other governments began to view the isotope industry as a high tech growth industry, and subsidized the production and sale of isotopes, targeting U.S. companies. The result is that U.S. industry has been switching its buying from the U.S. and DOE to foreign sources of supply.

This report provides an overview of the global Medical Isotopes market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Isotopes and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Isotopes revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Isotopes market.

Medical Isotopes Segment by Company

NRG

NTP Radioisotopes

JSC Isotope

ANSTO

IRE

Nordion

Curium Pharma

Cambridge Isotope Laboratories

Eckert & Ziegler Strahlen

Polatom

Center of Molecular Research

China National Nuclear Corporation

Urenco

LANL

Shanghai Engineering Research Center

IDB Holland

NHTC

Linde

ORNL

SI Science

Medical Isotopes Segment by Type

Stable Isotopes

Radioisotopes

Medical Isotopes Segment by Application

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Medical Isotopes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Isotopes status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Isotopes key companies, revenue, market share, and recent developments.

3. To split the Medical Isotopes breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Isotopes market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Isotopes significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Isotopes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Isotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Isotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Isotopes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Isotopes industry.

Chapter 3: Detailed analysis of Medical Isotopes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Isotopes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Isotopes in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Isotopes Industry Trends Table 2. Medical Isotopes Industry Drivers Table 3. Medical Isotopes Industry Opportunities and Challenges Table 4. Medical Isotopes Industry Restraints Table 5. Global Medical Isotopes Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Isotopes Revenue Share by Company (2021-2026) Table 7. Global Medical Isotopes Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Isotopes Key Company Manufacturing Base & Headquarters Table 9. Global Medical Isotopes Company, Product Type & Application Table 10. Global Medical Isotopes Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Isotopes by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Stable Isotopes Table 15. Significant Companies of Radioisotopes Table 16. Global Medical Isotopes Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Medical Isotopes Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Medical Isotopes Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Medical Isotopes Sales Value Share by Type (2021-2026) Table 20. Global Medical Isotopes Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Nuclear Therapy Table 22. Significant Companies of Equipment Radioactive Source Table 23. Significant Companies of Diagnosis Table 24. Global Medical Isotopes Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Medical Isotopes Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Medical Isotopes Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Medical Isotopes Sales Value Share by Application (2021-2026) Table 28. Global Medical Isotopes Sales Value Share by Application (2027-2032) Table 29. Global Medical Isotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Medical Isotopes Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Medical Isotopes Sales Value Share by Region (2021-2026) Table 32. Global Medical Isotopes Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Medical Isotopes Sales Value Share by Region (2027-2032) Table 34. Global Medical Isotopes Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Medical Isotopes Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Medical Isotopes Sales Value Market Share by Country (2021-2026) Table 37. Global Medical Isotopes Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Medical Isotopes Sales Value Market Share by Country (2027-2032) Table 39. NRG Company Information Table 40. NRG Business Overview Table 41. NRG Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. NRG Medical Isotopes Product Portfolio Table 43. NRG Recent Development Table 44. NTP Radioisotopes Company Information Table 45. NTP Radioisotopes Business Overview Table 46. NTP Radioisotopes Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. NTP Radioisotopes Medical Isotopes Product Portfolio Table 48. NTP Radioisotopes Recent Development Table 49. JSC Isotope Company Information Table 50. JSC Isotope Business Overview Table 51. JSC Isotope Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. JSC Isotope Medical Isotopes Product Portfolio Table 53. JSC Isotope Recent Development Table 54. ANSTO Company Information Table 55. ANSTO Business Overview Table 56. ANSTO Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ANSTO Medical Isotopes Product Portfolio Table 58. ANSTO Recent Development Table 59. IRE Company Information Table 60. IRE Business Overview Table 61. IRE Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. IRE Medical Isotopes Product Portfolio Table 63. IRE Recent Development Table 64. Nordion Company Information Table 65. Nordion Business Overview Table 66. Nordion Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Nordion Medical Isotopes Product Portfolio Table 68. Nordion Recent Development Table 69. Curium Pharma Company Information Table 70. Curium Pharma Business Overview Table 71. Curium Pharma Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Curium Pharma Medical Isotopes Product Portfolio Table 73. Curium Pharma Recent Development Table 74. Cambridge Isotope Laboratories Company Information Table 75. Cambridge Isotope Laboratories Business Overview Table 76. Cambridge Isotope Laboratories Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cambridge Isotope Laboratories Medical Isotopes Product Portfolio Table 78. Cambridge Isotope Laboratories Recent Development Table 79. Eckert & Ziegler Strahlen Company Information Table 80. Eckert & Ziegler Strahlen Business Overview Table 81. Eckert & Ziegler Strahlen Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio Table 83. Eckert & Ziegler Strahlen Recent Development Table 84. Polatom Company Information Table 85. Polatom Business Overview Table 86. Polatom Medical Isotopes Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Polatom Medical Isotopes Product Portfolio Table 88. Polatom Recent Development Table 89. Center of Molecular Research Company Information Table 90. Center of Molecular Research Business Overview Table 91. Center of Molecular Research Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Center of Molecular Research Medical Isotopes Product Portfolio Table 93. Center of Molecular Research Recent Development Table 94. China National Nuclear Corporation Company Information Table 95. China National Nuclear Corporation Business Overview Table 96. China National Nuclear Corporation Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. China National Nuclear Corporation Medical Isotopes Product Portfolio Table 98. China National Nuclear Corporation Recent Development Table 99. Urenco Company Information Table 100. Urenco Business Overview Table 101. Urenco Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Urenco Medical Isotopes Product Portfolio Table 103. Urenco Recent Development Table 104. LANL Company Information Table 105. LANL Business Overview Table 106. LANL Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. LANL Medical Isotopes Product Portfolio Table 108. LANL Recent Development Table 109. Shanghai Engineering Research Center Company Information Table 110. Shanghai Engineering Research Center Business Overview Table 111. Shanghai Engineering Research Center Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shanghai Engineering Research Center Medical Isotopes Product Portfolio Table 113. Shanghai Engineering Research Center Recent Development Table 114. IDB Holland Company Information Table 115. IDB Holland Business Overview Table 116. IDB Holland Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. IDB Holland Medical Isotopes Product Portfolio Table 118. IDB Holland Recent Development Table 119. NHTC Company Information Table 120. NHTC Business Overview Table 121. NHTC Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. NHTC Medical Isotopes Product Portfolio Table 123. NHTC Recent Development Table 124. Linde Company Information Table 125. Linde Business Overview Table 126. Linde Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Linde Medical Isotopes Product Portfolio Table 128. Linde Recent Development Table 129. ORNL Company Information Table 130. ORNL Business Overview Table 131. ORNL Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. ORNL Medical Isotopes Product Portfolio Table 133. ORNL Recent Development Table 134. SI Science Company Information Table 135. SI Science Business Overview Table 136. SI Science Medical Isotopes Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. SI Science Medical Isotopes Product Portfolio Table 138. SI Science Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Medical Isotopes Product Image Figure 2. Global Medical Isotopes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Isotopes Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Isotopes Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Stable Isotopes Image Figure 8. Radioisotopes Image Figure 9. Global Medical Isotopes Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Medical Isotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Medical Isotopes Sales Value Share by Type (2021-2032) Figure 12. Nuclear Therapy Image Figure 13. Equipment Radioactive Source Image Figure 14. Diagnosis Image Figure 15. Global Medical Isotopes Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Isotopes Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Isotopes Sales Value Share by Application (2021-2032) Figure 18. Global Medical Isotopes Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Medical Isotopes Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Medical Isotopes Sales Value (2021-2032) & (US$ Million) Figure 21. North America Medical Isotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Medical Isotopes Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Medical Isotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Medical Isotopes Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Medical Isotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Medical Isotopes Sales Value (2021-2032) & (US$ Million) Figure 27. South America Medical Isotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Medical Isotopes Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Medical Isotopes Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Medical Isotopes Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Medical Isotopes Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Medical Isotopes Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Stable Isotopes
  • Radioisotopes
Applications
  • Nuclear Therapy
  • Equipment Radioactive Source
  • Diagnosis
Companies covered
  • NRG
  • NTP Radioisotopes
  • JSC Isotope
  • ANSTO
  • IRE
  • Nordion
  • Curium Pharma
  • Cambridge Isotope Laboratories
  • Eckert & Ziegler Strahlen
  • Polatom
  • Center of Molecular Research
  • China National Nuclear Corporation
  • Urenco
  • LANL
  • Shanghai Engineering Research Center
  • IDB Holland
  • NHTC
  • Linde
  • ORNL
  • SI Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Isotopes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Isotopes Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Isotopes Market Dynamics
  1. 2.1 Medical Isotopes Industry Trends
  2. 2.2 Medical Isotopes Industry Drivers
  3. 2.3 Medical Isotopes Industry Opportunities and Challenges
  4. 2.4 Medical Isotopes Industry Restraints
3 Medical Isotopes Market by Company
  1. 3.1 Global Medical Isotopes Company Revenue Ranking in 2025
  2. 3.2 Global Medical Isotopes Revenue by Company (2021-2026)
  3. 3.3 Global Medical Isotopes Company Ranking (2024-2026)
  4. 3.4 Global Medical Isotopes Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Isotopes Company Product Type and Application
  6. 3.6 Global Medical Isotopes Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Isotopes Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Isotopes Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Isotopes Market by Type
  1. 4.1 Medical Isotopes Type Introduction
  2. 4.1.1 Stable Isotopes
  3. 4.1.2 Radioisotopes
  4. 4.2 Global Medical Isotopes Sales Value by Type
  5. 4.2.1 Global Medical Isotopes Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Medical Isotopes Sales Value by Type (2021-2032)
  7. 4.2.3 Global Medical Isotopes Sales Value Share by Type (2021-2032)
5 Medical Isotopes Market by Application
  1. 5.1 Medical Isotopes Application Introduction
  2. 5.1.1 Nuclear Therapy
  3. 5.1.2 Equipment Radioactive Source
  4. 5.1.3 Diagnosis
  5. 5.2 Global Medical Isotopes Sales Value by Application
  6. 5.2.1 Global Medical Isotopes Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Medical Isotopes Sales Value by Application (2021-2032)
  8. 5.2.3 Global Medical Isotopes Sales Value Share by Application (2021-2032)
6 Medical Isotopes Regional Value Analysis
  1. 6.1 Global Medical Isotopes Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Isotopes Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Isotopes Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Isotopes Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Isotopes Sales Value (2021-2032)
  7. 6.3.2 North America Medical Isotopes Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Isotopes Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Isotopes Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Isotopes Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Isotopes Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Isotopes Sales Value (2021-2032)
  16. 6.6.2 South America Medical Isotopes Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Isotopes Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Isotopes Sales Value Share by Country, 2025 VS 2032
7 Medical Isotopes Country-level Value Analysis
  1. 7.1 Global Medical Isotopes Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Isotopes Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Isotopes Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Isotopes Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Isotopes Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Isotopes Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Isotopes Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Isotopes Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Isotopes Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Isotopes Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Isotopes Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Isotopes Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Isotopes Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Isotopes Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Isotopes Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Isotopes Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Isotopes Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Isotopes Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Isotopes Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Isotopes Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Isotopes Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Isotopes Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Isotopes Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Isotopes Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Isotopes Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Isotopes Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Isotopes Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Isotopes Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Isotopes Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Isotopes Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Isotopes Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Isotopes Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Isotopes Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Isotopes Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Isotopes Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 NRG
  2. 8.1.1 NRG Company Information
  3. 8.1.2 NRG Business Overview
  4. 8.1.3 NRG Medical Isotopes Revenue and Gross Margin (2021-2026)
  5. 8.1.4 NRG Medical Isotopes Product Portfolio
  6. 8.1.5 NRG Recent Developments
  7. 8.2 NTP Radioisotopes
  8. 8.2.1 NTP Radioisotopes Company Information
  9. 8.2.2 NTP Radioisotopes Business Overview
  10. 8.2.3 NTP Radioisotopes Medical Isotopes Revenue and Gross Margin (2021-2026)
  11. 8.2.4 NTP Radioisotopes Medical Isotopes Product Portfolio
  12. 8.2.5 NTP Radioisotopes Recent Developments
  13. 8.3 JSC Isotope
  14. 8.3.1 JSC Isotope Company Information
  15. 8.3.2 JSC Isotope Business Overview
  16. 8.3.3 JSC Isotope Medical Isotopes Revenue and Gross Margin (2021-2026)
  17. 8.3.4 JSC Isotope Medical Isotopes Product Portfolio
  18. 8.3.5 JSC Isotope Recent Developments
  19. 8.4 ANSTO
  20. 8.4.1 ANSTO Company Information
  21. 8.4.2 ANSTO Business Overview
  22. 8.4.3 ANSTO Medical Isotopes Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ANSTO Medical Isotopes Product Portfolio
  24. 8.4.5 ANSTO Recent Developments
  25. 8.5 IRE
  26. 8.5.1 IRE Company Information
  27. 8.5.2 IRE Business Overview
  28. 8.5.3 IRE Medical Isotopes Revenue and Gross Margin (2021-2026)
  29. 8.5.4 IRE Medical Isotopes Product Portfolio
  30. 8.5.5 IRE Recent Developments
  31. 8.6 Nordion
  32. 8.6.1 Nordion Company Information
  33. 8.6.2 Nordion Business Overview
  34. 8.6.3 Nordion Medical Isotopes Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nordion Medical Isotopes Product Portfolio
  36. 8.6.5 Nordion Recent Developments
  37. 8.7 Curium Pharma
  38. 8.7.1 Curium Pharma Company Information
  39. 8.7.2 Curium Pharma Business Overview
  40. 8.7.3 Curium Pharma Medical Isotopes Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Curium Pharma Medical Isotopes Product Portfolio
  42. 8.7.5 Curium Pharma Recent Developments
  43. 8.8 Cambridge Isotope Laboratories
  44. 8.8.1 Cambridge Isotope Laboratories Company Information
  45. 8.8.2 Cambridge Isotope Laboratories Business Overview
  46. 8.8.3 Cambridge Isotope Laboratories Medical Isotopes Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cambridge Isotope Laboratories Medical Isotopes Product Portfolio
  48. 8.8.5 Cambridge Isotope Laboratories Recent Developments
  49. 8.9 Eckert & Ziegler Strahlen
  50. 8.9.1 Eckert & Ziegler Strahlen Company Information
  51. 8.9.2 Eckert & Ziegler Strahlen Business Overview
  52. 8.9.3 Eckert & Ziegler Strahlen Medical Isotopes Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Eckert & Ziegler Strahlen Medical Isotopes Product Portfolio
  54. 8.9.5 Eckert & Ziegler Strahlen Recent Developments
  55. 8.10 Polatom
  56. 8.10.1 Polatom Company Information
  57. 8.10.2 Polatom Business Overview
  58. 8.10.3 Polatom Medical Isotopes Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Polatom Medical Isotopes Product Portfolio
  60. 8.10.5 Polatom Recent Developments
  61. 8.11 Center of Molecular Research
  62. 8.11.1 Center of Molecular Research Company Information
  63. 8.11.2 Center of Molecular Research Business Overview
  64. 8.11.3 Center of Molecular Research Medical Isotopes Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Center of Molecular Research Medical Isotopes Product Portfolio
  66. 8.11.5 Center of Molecular Research Recent Developments
  67. 8.12 China National Nuclear Corporation
  68. 8.12.1 China National Nuclear Corporation Company Information
  69. 8.12.2 China National Nuclear Corporation Business Overview
  70. 8.12.3 China National Nuclear Corporation Medical Isotopes Revenue and Gross Margin (2021-2026)
  71. 8.12.4 China National Nuclear Corporation Medical Isotopes Product Portfolio
  72. 8.12.5 China National Nuclear Corporation Recent Developments
  73. 8.13 Urenco
  74. 8.13.1 Urenco Company Information
  75. 8.13.2 Urenco Business Overview
  76. 8.13.3 Urenco Medical Isotopes Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Urenco Medical Isotopes Product Portfolio
  78. 8.13.5 Urenco Recent Developments
  79. 8.14 LANL
  80. 8.14.1 LANL Company Information
  81. 8.14.2 LANL Business Overview
  82. 8.14.3 LANL Medical Isotopes Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LANL Medical Isotopes Product Portfolio
  84. 8.14.5 LANL Recent Developments
  85. 8.15 Shanghai Engineering Research Center
  86. 8.15.1 Shanghai Engineering Research Center Company Information
  87. 8.15.2 Shanghai Engineering Research Center Business Overview
  88. 8.15.3 Shanghai Engineering Research Center Medical Isotopes Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Shanghai Engineering Research Center Medical Isotopes Product Portfolio
  90. 8.15.5 Shanghai Engineering Research Center Recent Developments
  91. 8.16 IDB Holland
  92. 8.16.1 IDB Holland Company Information
  93. 8.16.2 IDB Holland Business Overview
  94. 8.16.3 IDB Holland Medical Isotopes Revenue and Gross Margin (2021-2026)
  95. 8.16.4 IDB Holland Medical Isotopes Product Portfolio
  96. 8.16.5 IDB Holland Recent Developments
  97. 8.17 NHTC
  98. 8.17.1 NHTC Company Information
  99. 8.17.2 NHTC Business Overview
  100. 8.17.3 NHTC Medical Isotopes Revenue and Gross Margin (2021-2026)
  101. 8.17.4 NHTC Medical Isotopes Product Portfolio
  102. 8.17.5 NHTC Recent Developments
  103. 8.18 Linde
  104. 8.18.1 Linde Company Information
  105. 8.18.2 Linde Business Overview
  106. 8.18.3 Linde Medical Isotopes Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Linde Medical Isotopes Product Portfolio
  108. 8.18.5 Linde Recent Developments
  109. 8.19 ORNL
  110. 8.19.1 ORNL Company Information
  111. 8.19.2 ORNL Business Overview
  112. 8.19.3 ORNL Medical Isotopes Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ORNL Medical Isotopes Product Portfolio
  114. 8.19.5 ORNL Recent Developments
  115. 8.20 SI Science
  116. 8.20.1 SI Science Company Information
  117. 8.20.2 SI Science Business Overview
  118. 8.20.3 SI Science Medical Isotopes Revenue and Gross Margin (2021-2026)
  119. 8.20.4 SI Science Medical Isotopes Product Portfolio
  120. 8.20.5 SI Science Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst